Skip to main content
. 2024 Nov 28;9(11):e017177. doi: 10.1136/bmjgh-2024-017177

Figure 3. Geographical location of study sites of incretin-based clinical trials for obesity. (A) Prevalence of study sites by continent. (B) Prevalence of study sites in low and middle, and high-income countries according to World Bank. (C) Global prevalence and projected estimates of obesity in low and middle, and high-income countries according to World Bank (years 2020, 2025 and 2035).

Figure 3

HHS Vulnerability Disclosure